The correctors lumacaftor (VX-809), tezacaftor (VX-661), elaxacaftor (VX-445) and the potentiator ivacaftor (VX-770) are CFTR modulators currently used in the therapy of CF [17–19]. This evidence concerns the gene CFTR and cystic fibrosis.